Peng L et al. verified that AR could be directly combined with LAMA4, and it was related to enhanced cisplatin resistance in gastric cancer, providing a new mechanism for the treatment of drug-resistant gastric cancer [30]. The gene discussed is AR; the disease is gastric cancer.